Literature DB >> 16272520

Use of four dengue virus antigens for determination of dengue immune status by enzyme-linked immunosorbent assay of immunoglobulin G avidity.

Séverine Matheus1, Xavier Deparis, Bhety Labeau, Josiane Lelarge, Jacques Morvan, Philippe Dussart.   

Abstract

We used an enzyme-linked immunosorbent assay (ELISA) of immunoglobulin G avidity to determine the dengue immune status of 105 pairs of serum samples from patients infected with dengue virus. This study shows that a simple avidity test, for which only one acute-phase serum sample is required, is potentially more useful than the hemagglutination inhibition test for the discrimination of primary from secondary dengue virus infection, whatever the type of dengue antigen used.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16272520      PMCID： PMC1287789          DOI： 10.1128/JCM.43.11.5784-5786.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Cross-reactivity in flavivirus serology: new implications of an old finding?

Authors:  R Allwinn; H W Doerr; P Emmerich; H Schmitz; W Preiser
Journal:  Med Microbiol Immunol       Date:  2002-03       Impact factor: 3.402

2.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.

Authors:  R S Lanciotti; C H Calisher; D J Gubler; G J Chang; A V Vorndam
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

3.  Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections.

Authors:  Vanda Akico Ueda Fick de Souza; Silvana Fernandes; Evaldo Stanislau Araújo; Adriana Fumie Tateno; Olímpia M N P F Oliveira; Renato Reis Oliveira; Cláudio Sérgio Pannuti
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

4.  Rapid diagnosis of hantavirus disease with an IgG-avidity assay.

Authors:  K Hedman; A Vaheri; M Brummer-Korvenkontio
Journal:  Lancet       Date:  1991-11-30       Impact factor: 79.321

5.  Detection of IgM antibodies from cerebrospinal fluid and sera of dengue fever patients.

Authors:  W J Chen; K P Hwang; A H Fang
Journal:  Southeast Asian J Trop Med Public Health       Date:  1991-12       Impact factor: 0.267

6.  An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.

Authors:  B L Innis; A Nisalak; S Nimmannitya; S Kusalerdchariya; V Chongswasdi; S Suntayakorn; P Puttisri; C H Hoke
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

7.  [MAC-ELISA for the detection of IgM antibodies to dengue type I virus (rapid diagnosis of dengue type I virus infection)].

Authors:  L Chow; S T Hsu
Journal:  Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi       Date:  1989-11

8.  Measurement of avidity of specific IgG for verification of recent primary rubella.

Authors:  K Hedman; S A Rousseau
Journal:  J Med Virol       Date:  1989-04       Impact factor: 2.327

9.  Avidity of IgG antibodies to human herpesvirus-6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross-reactivity with other herpesviruses.

Authors:  K N Ward; J J Gray; M E Joslin; M J Sheldon
Journal:  J Med Virol       Date:  1993-01       Impact factor: 2.327

10.  Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.

Authors:  S B Halstead; E J O'Rourke
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307
View more
  7 in total

1.  Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.

Authors:  Simona Zompi; Brian H Santich; P Robert Beatty; Eva Harris
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

2.  Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

3.  Primary and probable secondary dengue virus (DV) infection rates in relation to age among DV IgM-positive patients residing in the United States mainland versus the Caribbean islands.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

4.  Avidity of anti-neurocytoskeletal antibodies in cerebrospinal fluid and serum.

Authors:  L Fialová; J Švarcová; A Bartos; I Malbohan
Journal:  Folia Microbiol (Praha)       Date:  2012-05-08       Impact factor: 2.099

5.  Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans.

Authors:  Andreas Puschnik; Louis Lau; Elizabeth A Cromwell; Angel Balmaseda; Simona Zompi; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13

6.  Discriminating malaria from dengue fever in endemic areas: clinical and biological criteria, prognostic score and utility of the C-reactive protein: a retrospective matched-pair study in French Guiana.

Authors:  Loïc Epelboin; Charlotte Boullé; Sihem Ouar-Epelboin; Matthieu Hanf; Philippe Dussart; Félix Djossou; Mathieu Nacher; Bernard Carme
Journal:  PLoS Negl Trop Dis       Date:  2013-09-12

7.  Comparison of the Hemagglutination Inhibition Test and IgG ELISA in Categorizing Primary and Secondary Dengue Infections Based on the Plaque Reduction Neutralization Test.

Authors:  Nurhayati Lukman; Gustiani Salim; Herman Kosasih; Nugroho Harry Susanto; Ida Parwati; Silvita Fitri; Bachti Alisjahbana; Susana Widjaja; Maya Williams
Journal:  Biomed Res Int       Date:  2016-06-30       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.